Baxter Ventures has led a $10m series B round for Prescient Surgical, which also attracted corporate-backed Summation Health Ventures.
US-based medical device developer Prescient Surgical raised $10m yesterday in a series B round led by Baxter Ventures, the strategic investment unit of medical products maker Baxter International.
Summation Health Ventures, the venture capital fund formed by healthcare systems Cedars-Sinai and MemorialCare, private equity firm CWC HealthTech Advisors and Stanford University’s Standford-StartX Fund also joined the round.
Prescient Surgical designs and develops tools and technologies to combat the sources of surgical site infection. Its flagship product, CleanCision, removes contamination and…
